Effects of Treatment of Ovariectomized Adult Rhesus Monkeys with Parathyroid Hormone 1-84 for 16 Months on Trabecular and Cortical Bone Structure and Biomechanical Properties of the Proximal Femur

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Calcified Tissue International

• Publication date

  2007-06-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00223-007-9036-yPMID 17551766
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys.

  2007cited by this paper
• Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with Osteoporosis

  2007cited by this paper
• Daily Treatment of Aged Ovariectomized Rats with Human Parathyroid Hormone (1-84) for 12 Months Reverses Bone Loss and Enhances Trabecular and Cortical Bone Strength

  2006cited by this paper
• Treatment of Skeletally Mature Ovariectomized Rhesus Monkeys With PTH(1‐84) for 16 Months Increases Bone Formation and Density and Improves Trabecular Architecture and Biomechanical Properties at the Lumbar Spine

  2006cited by this paper
• Treatment of postmenopausal osteoporotic women with parathyroid hormone 1-84 for 18 months increases cancellous bone formation and improves cancellous architecture: a study of iliac crest biopsies using histomorphometry and micro computed tomography.

  2005cited by this paper
• Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass.

  2005cited by this paper
• Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis.

  2004cited by this paper
• SAS for Linear Models (4th ed.)

  2004cited by this paper
• Teriparatide [PTH(1–34)] Strengthens the Proximal Femur of Ovariectomized Nonhuman Primates Despite Increasing Porosity

  2004cited by this paper
• Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis

  2003cited by this paper
• Effects of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] on Cortical Bone in Postmenopausal Women With Osteoporosis

  2003influential reference
• Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis.

  2003cited by this paper
• The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.

  2003cited by this paper
• Biomechanics of Bone: Determinants of Skeletal Fragility and Bone Quality

  2002cited by this paper
• A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis.

  2002cited by this paper
• SAS for Linear Models

  2002cited by this paper
• The effect of monocyclic and bicyclic analogs of human parathyroid hormone (hPTH)-(1-31)NH2 on bone formation and mechanical strength in ovariectomized rats

  2001cited by this paper
• Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis).

  2001cited by this paper
• Intermittently Administered Human Parathyroid Hormone(1–34) Treatment Increases Intracortical Bone Turnover and Porosity Without Reducing Bone Strength in the Humerus of Ovariectomized Cynomolgus Monkeys

  2001cited by this paper
• Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

  2001cited by this paper
• Six‐Month Daily Administration of Parathyroid Hormone and Parathyroid Hormone—Related Protein Peptides to Adult Ovariectomized Rats Markedly Enhances Bone Mass and Biomechanical Properties: A Comparison of Human Parathyroid Hormone 1–34, Parathyroid Hormone‐Related Protein 1–36, and SDZ‐Parathyroid

  2000cited by this paper
• Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys.

  1999cited by this paper
• Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).

  1999cited by this paper
• Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.

  1998cited by this paper
• Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency.

  1998cited by this paper
• Zoledronate Prevents the Development of Absolute Osteopenia Following Ovariectomy in Adult Rhesus Monkeys

  1998cited by this paper
• Decreased Bone Mass and Strength in Ovariectomized Cynomolgus Monkeys (Macaca fascicularis)

  1997cited by this paper
• The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.

  1993cited by this paper
• Population-based study of survival after osteoporotic fractures.

  1993cited by this paper
• The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84).

  1991cited by this paper
• Bone histomorphometry: standardization of nomenclature, symbols and units (summary of proposed system).

  1988cited by this paper
• Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

  1987cited by this paper

• Fracture healing: cellular mechanisms and impact of parathyroid hormone and its analogs

  2025cites this paper
• Enhancing bone regeneration and osseointegration using rhPTH(1-34) and dimeric R25CPTH(1-34) in an osteoporotic beagle model

  2024cites this paper
• Is the Jaw Bone Micro-Structure Altered in Response to Osteoporosis and Bisphosphonate Treatment? A Micro-CT Analysis

  2021cites this paper
• Cellular actions of parathyroid hormone on bone

  2020cites this paper
• Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosis

  2020cites this paper
• Parathyroid hormone for bone regeneration

  2018cites this paper
• Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption

  2017cites this paper
• Ovarian hormone depletion affects cortical bone quality differently on different skeletal envelopes.

  2017cites this paper
• Effects of long term treatment with high doses of odanacatib on bone mass, bone strength, and remodeling/modeling in newly ovariectomized monkeys.

  2016cites this paper
• Effect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats.

  2014cites this paper
• Arthritis, Muscle, Adipose Tissue, and Bone Diseases of Nonhuman Primates

  2012cites this paper
• Femoral strength in osteoporotic women treated with teriparatide or alendronate.

  2012cites this paper
• Fragile Spines on Cayo Santiago: Bone Mineral Density, Trabecular Morphology, and the Potential for Exploring the Genetics of Osteoporosis in Rhesus Monkeys

  2012cites this paper
• Effects of ovariectomy on rat mandibular cortical bone: a study using Raman spectroscopy and multivariate analysis.

  2012cites this paper
• Großtiermodelle der Osteoporose

  2011cites this paper
• The influence of parathyroid hormone treatment on implant fixation.

  2011cites this paper
• Nonhuman Primate Models of Osteoporosis

  2011cites this paper
• Differential Maintenance of Cortical and Cancellous Bone Strength Following Discontinuation of Bone-Active Agents

  2010cites this paper
• Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.

  2009cites this paper
• Skeletal health: primate model of postmenopausal osteoporosis

  2009influential citation
• Effects of Treatment with Parathyroid Hormone 1–84 on Quantity and Biomechanical Properties of Thoracic Vertebral Trabecular Bone in Ovariectomized Rhesus Monkeys

  2008cites this paper
• ZT-031, a cyclized analog of parathyroid hormone(1-31) for the potential treatment of osteoporosis.

  2008cites this paper
• Parathyroids , bone and mineral metabolism Anabolic therapies for osteoporosis

  2008cites this paper
• Intratrabecular tunneling increases trabecular number throughout the skeleton of ovariectomized rhesus monkeys treated with parathyroid hormone 1-84.

  2008cites this paper